Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHIRP01: RSV Controlled Human Infection in Older Adults
NCT06274619Completed
- Sponsor
- Imperial College London
- Start
- Mar 2024
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Imperial College London. Primary endpoints: Number of Solicited and Unsolicited Adverse Events at 28 days and Infection Rate at 10 days. Started Mar 2024; status: completed.
Beyond the preview
Go deeper on NCT06274619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06274619.